Connect with us

Berita

Diklat Integrasi, Upaya TNI-Polri Pererat Soliditas dan Redam Gesekan Antar Anggota

Published

on

Komandan Komando Pembinaan Doktrin Pendidikan dan Latihan (Dankodiklat) TNI AL Letjen TNI (Mar) Suhartono melihat kegiatan diklat integrasi siswa Sepolwan dengan Diktukba TNI AD, AU dan AL adalah hal yang bagus. Ia pun menyebut kekompakan antara siswa Sepolwan dan Diktukba TNI AD, AU dan AL sudah terlihat meskipun baru beberapa hari menjalani diklat bersama.

“Meskipun pelaksanaan baru beberapa hari tapi sudah terlihat kekompakannya dan kegiatan bisa berbaur. Saya lihat secara langsung mereka semua bisa menyatu,” ujar Suhartono saat kunjungan ke Sepolwan Polri, di Jakarta, Rabu (14/12/2022).

Suhartono menyebut, kekompakan yang ditunjukan para siswa merupakan gambaran soliditas TNI-Polri yang sangat bagus dari awal lembaga pendidikan. Apalagi, kata Suhartono, selama ini belum terselenggara pendidikan bersama siswa TNI-Polri di level bintara dan tamtama.

“Sehingga hal ini menjadi awal sebuah kegiatan yang kedepan kita laksanakan terus menerus,” katanya.

Dengan adanya program integrasi ini, Suhartono menjelaskan masing-masing siswa akan saling memahami dan memiliki wawasan bagaimana sejarah TNI dan Polri di negeri ini, yang artinya setiap anggota TNI-Polri punya peran masing masing.

Selain itu, para siswa juga dapat memahami tentang tugas masing-masing institusi, baik TNI maupun Polri. Sehingga akan terjadi pemahaman merata di jajaran anggota dan setelah itu akan terjadi rasa saling menghormati.

“Dua institusi TNI dan Polri adalah dua komponen bangsa yang tidak bisa di pecah belah dan tidak bisa diprovokasi. Jika nanti ada permasalahan pun di bawah bisa cepat meredam dan menyelesaikan secara individu,” katanya.

Terkait kegiatan diklat integrasi ini, Suhartono menyampaikan bahwa hal ini sebagai implementasi perjanjian kerja sama antara TNI AL dan Polri. Ia pun sudah melaporkan kegiatan ini kepada KSAL Laksamana Yudo Margono.

“Beliau (KSAL) sangat antusias untuk tahun di tindak lanjuti. Saya evaluasi pelaksanaan sekarang kira-kira ke depan bentuknya seperti apa. Yang jelas dari beliau (KSAL) menyampaikan kalau satu minggu (pelaksanaan diklat integrasi) itu kurang. Itu harus lebih, minimal kegiatan ini satu bulan. Kami akan kordinasikan apalagi darat (TNI AD) dan udara (TNI AU) sudah gabung sehingga akan kita sinkronkan agar matching kegiatannya,” katanya.

Sementara itu, Pati Lemdiklat Polri Irjen Mohamad Asep Syahrudin mengibaratkan kegiatan diklat integrasi ini adalah sebuah bingkat bentuk keanekaragaman suku bangsa di Indonesia. Dimana keanekagaraman ini ibarat puzzle dalam satu bidang yang apabila bingkainya tidak kokoh maka akan tersebar lebar.

“Siapa yang menjadi bingkainya itu TNI-Polri,” katanya.

Selama ini, kata Asep, TNI-Polri selalu ada kerja sama pendidikan untuk level manajemen menengah dan tinggi. Saat ini, sudah dua tahun berjalan terlaksana kerja sama pendidikan untuk level pama dan bintara serta tamtama.

Menurutnya, kerja sama pendidikan di level terbawah penting dilakukan untuk menekan gesekan antar anggota TNI-Polri yang kerap terjadi di tingkat terbawah.

“Ini penting karena peristiwa gesekan-gesekan terjadi di level bawah. Nah dengan adanya kegiatan ini konsekuensinya adalah akan menekan hal serupa tak terjadi. Kalaupun terjadi dapat terselesaikan karena mereka membangun ikatan sodara asuh antara bintara dan tamtama TNI-Polri,” ujarnya.

Continue Reading
Click to comment

Leave a Reply

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

tc-check-test1

Published

on

tc-manager precheck test1 – https://test1.com

Continue Reading

Trending